UNH vs BMY
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Bristol-Myers Squibb Company, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | BMY |
|---|---|---|
| Price | $427.89 | $57.52 |
| Market cap | $388.59B | $117.46B |
| P/E ratio | 32.3 | 16.1 |
| ROE | 12.18% | 38.73% |
| Profit margin | 2.68% | 15.01% |
| Revenue growth | 2.00% | 2.60% |
| Dividend yield | 2.17% | 4.38% |
| Beta | 0.65 | 0.24 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs BMY in plain English
- UNH is the bigger company — about 3.3× the market cap of BMY.
- BMY is cheaper on earnings (P/E 16.1 vs 32.3).
- BMY earns a higher return on equity (39% vs 12%).
- BMY is growing revenue faster (3% vs 2%).
- BMY has the higher dividend yield (4.38% vs 2.17%).
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
BMY return calculator
See what $1,000 in Bristol-Myers Squibb Company would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.